Literature DB >> 28474633

Echocardiographic abnormalities in cirrhosis & their correlation with severity of cirrhosis using Child-Pugh score among patients in a tertiary care hospital.

Jagruti Balde1, N Karthik Rao1, Kirthinath Ballala2, Jyothi Samanth3, K Ranjan Shetty4, Navin Patil5, A Avinash5, George Varghese1.   

Abstract

BACKGROUND &
OBJECTIVES: Child-Pugh score (CPS) is a widely used prognostic marker in cases of cirrhosis and pulmonary arterial hypertension (PAH). However, the role of this score in the quantification of severity of PAH is not well studied. In mild cases, echocardiography is more sensitive. This study was done to assess the association between echocardiography and severity of cirrhosis using CPS.
METHODS: A cross-sectional study was done from April to June 2014 in 42 patients with cirrhosis using a pre-tested semi-structured interview schedule.
RESULTS: There was no significant association between echocardiographic changes and CPS in patients with liver cirrhosis. INTERPRETATION &
CONCLUSIONS: Advising an echocardiographic evaluation may prove beneficial in patients of Child-Pugh Grades B and C. However, more extensive studies are required to confirm the same.

Entities:  

Mesh:

Year:  2016        PMID: 28474633      PMCID: PMC5433289          DOI: 10.4103/ijmr.IJMR_1486_15

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  14 in total

1.  Portopulmonary hypertension: Results from a 10-year screening algorithm.

Authors:  Michael J Krowka; Karen L Swanson; Robert P Frantz; Michael D McGoon; Russell H Wiesner
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

2.  Incidence, etiology and mortality of cirrhosis: a population-based cohort study.

Authors:  Annette Dam Fialla; Ove B Schaffalitzky de Muckadell; Annmarie Touborg Lassen
Journal:  Scand J Gastroenterol       Date:  2012-03-19       Impact factor: 2.423

Review 3.  Pulmonary vascular complications in portal hypertension and liver disease: a concise review.

Authors:  M Porres-Aguilar; J F Gallegos-Orozco; H Garcia; J Aguirre; R U Macias-Rodriguez; A Torre-Delgadillo
Journal:  Rev Gastroenterol Mex       Date:  2013-01-28

4.  Distinctive clinical features of portopulmonary hypertension.

Authors:  P C Kuo; J S Plotkin; L B Johnson; C D Howell; J M Laurin; S T Bartlett; L J Rubin
Journal:  Chest       Date:  1997-10       Impact factor: 9.410

5.  Pulmonary hypertension associated with liver cirrhosis: an echocardiographic study.

Authors:  M Auletta; U Oliviero; L Iasiuolo; G Scherillo; S Antoniello
Journal:  Angiology       Date:  2000-12       Impact factor: 3.619

6.  Evaluation of cardiac function in patients with liver cirrhosis.

Authors:  Tarek A Abd-El-Aziz; Mohamed Abdou; Ahmed Fathy; Mohamed Wafaie
Journal:  Intern Med       Date:  2010-12-01       Impact factor: 1.271

7.  Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.

Authors:  Francisco Sampaio; Joana Pimenta; Nuno Bettencourt; Ricardo Fontes-Carvalho; Ana P Silva; João Valente; Paulo Bettencourt; José Fraga; Vasco Gama
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

8.  Pulmonary arteriovenous malformation in cryptogenic liver cirrhosis.

Authors:  Noureen Afzal; Saleem Akhtar; Shakeel Ahmed; Mehnaz Atiq
Journal:  J Coll Physicians Surg Pak       Date:  2013-09       Impact factor: 0.711

9.  Pulmonary complications in cirrhotic candidates for liver transplantation.

Authors:  Seiyed Mohammad Ali Ghayumi; Samrad Mehrabi; Mahmood Zamirian; Javad Haseli; Kamran Bagheri Lankarani
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

10.  Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.

Authors:  Svanhildur Haflidadottir; Jon G Jonasson; Helga Norland; Sylvia O Einarsdottir; David E Kleiner; Sigrun H Lund; Einar S Björnsson
Journal:  BMC Gastroenterol       Date:  2014-09-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.